“…Nuclear hormone receptors (retinoic acid receptor RAR and retinoids X receptor RXR, each of which has three subtypes) and cytosolic binding proteins modulate their biological functions [9]. RAMBAs, such as liarozole, have been discovered and studied to treat all-trans-retinoic acid resistance [5,11]. Topical retinoids currently include tretinoin, adapalene, tazarotene, isotretinoin, metretinide, retinaldehyde, and retinoyl glucuronide.…”